Första patienten behandlad med C-RADs högteknologiska positioneringssystem vid cancercentret i Negrar-Verona, Italien

NEXT STORY
The Clinical Laboratory Services Market to 2023 by Specialty, Provider Group, Region, Key Player
PREV STORY
Biocartis Group NV: BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zentalis Pharmaceuticals Announces Publication in the Journal of Medicinal Chemistry Highlighting the Discovery of its WEE1 Inhibitor Candidate ZN-c3

author_avatar
NASDAQ Market News

Dr. Keith Nemec of Total Health Institute discusses cancer stem cells for cancer treatment

author_avatar
NASDAQ Market News

Valeritas ENABLE Study Demonstrates Significant Clinical Benefits of V-Go in Patients with Type 2 Diabetes Who Switched from Insulin Pens and Syringes

- Data Presented at Annual ADA Meeting Reports Patients with Type 2 Diabetes who ...

author_avatar
NASDAQ Market News